SH2D1A: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
 
m (→‎Further reading: task, replaced: International Journal of Cancer. Journal International Du Cancer → International Journal of Cancer using AWB)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''SH2 domain–containing protein 1A''' is a [[protein]] that in humans is encoded by the ''SH2D1A'' [[gene]].<ref name="pmid9771704">{{cite journal | vauthors = Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR | title = Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene | journal = Nature Genetics | volume = 20 | issue = 2 | pages = 129–35 | date = Oct 1998 | pmid = 9771704 | pmc =  | doi = 10.1038/2424 }}</ref><ref name="pmid9774102">{{cite journal | vauthors = Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C | title = The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM | journal = Nature | volume = 395 | issue = 6701 | pages = 462–9 | date = Oct 1998 | pmid = 9774102 | pmc =  | doi = 10.1038/26683 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: SH2D1A SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4068| accessdate = }}</ref> It is often called '''SLAM-associated protein''' (symbol '''SAP'''), where "SLAM" refers to [[signaling lymphocytic activation molecule]]s. It is a [[SH2 domain]]–containing molecule (part of a [http://www.genenames.org/cgi-bin/genefamilies/set/741 family of such molecules]) that plays a role in SLAM [[cell signaling|signaling]]. A putative function is as an adaptor for [[FYN|Fyn]] and competitor of [[phosphatase]]s, leading to modulation of SLAM family function. SAP has been implicated in [[autoimmunity]],<ref>{{cite journal | vauthors = Menard M ''et al'' | year = 2014 | title = Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance | url = | journal = Journal of Allergy and Clinical Immunology | volume = 133 | issue = 4| pages = 1149–1161 | doi=10.1016/j.jaci.2013.10.051}}</ref> and a [[mutation]] of it is associated with [[X-linked lymphoproliferative disease]].
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== Interactions ==
{{GNF_Protein_box
| image = PBB_Protein_SH2D1A_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1d1z.
| PDB = {{PDB2|1d1z}}, {{PDB2|1d4t}}, {{PDB2|1d4w}}, {{PDB2|1ka6}}, {{PDB2|1ka7}}, {{PDB2|1m27}}
| Name = SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome)
| HGNCid = 10820
| Symbol = SH2D1A
| AltSymbols =; SAP; DSHP; EBVS; IMD5; LYP; MTCP1; XLP; XLPD
| OMIM = 300490
| ECnumber = 
| Homologene = 1762
| MGIid = 1328352
| GeneAtlas_image1 = PBB_GE_SH2D1A_210116_at_tn.png
| GeneAtlas_image2 = PBB_GE_SH2D1A_211209_x_at_tn.png
| GeneAtlas_image3 = PBB_GE_SH2D1A_211210_x_at_tn.png
| Function = {{GNF_GO|id=GO:0005070 |text = SH3/SH2 adaptor activity}}
| Component = {{GNF_GO|id=GO:0005737 |text = cytoplasm}}
| Process = {{GNF_GO|id=GO:0006959 |text = humoral immune response}} {{GNF_GO|id=GO:0006968 |text = cellular defense response}} {{GNF_GO|id=GO:0007242 |text = intracellular signaling cascade}} {{GNF_GO|id=GO:0007267 |text = cell-cell signaling}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 4068
    | Hs_Ensembl = ENSG00000183918
    | Hs_RefseqProtein = NP_002342
    | Hs_RefseqmRNA = NM_002351
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = X
    | Hs_GenLoc_start = 123307875
    | Hs_GenLoc_end = 123334686
    | Hs_Uniprot = O60880
    | Mm_EntrezGene = 20400
    | Mm_Ensembl = ENSMUSG00000005696
    | Mm_RefseqmRNA = XM_903301
    | Mm_RefseqProtein = XP_908394
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = X
    | Mm_GenLoc_start = 38747189
    | Mm_GenLoc_end = 38766724
    | Mm_Uniprot = Q544F1
  }}
}}
'''SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome)''', also known as '''SH2D1A''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: SH2D1A SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4068| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
SH2D1A has been shown to [[Protein-protein interaction|interact]] with:
{{PBB_Summary
* [[CD84]],<ref name = pmid12928397>{{cite journal | vauthors = Tangye SG, Nichols KE, Hare NJ, van de Weerdt BC | title = Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation | journal = Journal of Immunology | volume = 171 | issue = 5 | pages = 2485–95 | date = Sep 2003 | pmid = 12928397 | doi =  10.4049/jimmunol.171.5.2485}}</ref><ref name = pmid11389028>{{cite journal | vauthors = Sayós J, Martín M, Chen A, Simarro M, Howie D, Morra M, Engel P, Terhorst C | title = Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP | journal = Blood | volume = 97 | issue = 12 | pages = 3867–74 | date = Jun 2001 | pmid = 11389028 | doi =  10.1182/blood.v97.12.3867}}</ref><ref name = pmid12115647>{{cite journal | vauthors = Tangye SG, van de Weerdt BC, Avery DT, Hodgkin PD | title = CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2 | journal = European Journal of Immunology | volume = 32 | issue = 6 | pages = 1640–9 | date = Jun 2002 | pmid = 12115647 | doi = 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S }}</ref><ref name = pmid11477068/>
| section_title =  
* [[DOK1]],<ref name = pmid10852966>{{cite journal | vauthors = Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E | title = The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 13 | pages = 7470–5 | date = Jun 2000 | pmid = 10852966 | pmc = 16569 | doi = 10.1073/pnas.130193097 }}</ref>
| summary_text =  
* [[FYN]],<ref name = pmid12458214>{{cite journal | vauthors = Li C, Iosef C, Jia CY, Han VK, Li SS | title = Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors | journal = The Journal of Biological Chemistry | volume = 278 | issue = 6 | pages = 3852–9 | date = Feb 2003 | pmid = 12458214 | doi = 10.1074/jbc.M206649200 }}</ref><ref name = pmid12545174>{{cite journal | vauthors = Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, Eck MJ | title = SAP couples Fyn to SLAM immune receptors | journal = Nature Cell Biology | volume = 5 | issue = 2 | pages = 155–60 | date = Feb 2003 | pmid = 12545174 | doi = 10.1038/ncb920 }}</ref>
}}
* [[LY9]]<ref name = pmid11389028/><ref name = pmid11477068/> and
* [[SLAMF1]].<ref name = pmid11477068>{{cite journal | vauthors = Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C | title = Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients | journal = The Journal of Biological Chemistry | volume = 276 | issue = 39 | pages = 36809–16 | date = Sep 2001 | pmid = 11477068 | doi = 10.1074/jbc.M101305200 }}</ref><ref name = pmid11806999>{{cite journal | vauthors = Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C | title = Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation | journal = Blood | volume = 99 | issue = 3 | pages = 957–65 | date = Feb 2002 | pmid = 11806999 | doi = 10.1182/blood.v99.3.957}}</ref>


==References==
== References ==
{{reflist|2}}
{{Reflist|33em}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | author=Sumegi J, Seemayer TA, Huang D, ''et al.'' |title=A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. |journal=Leuk. Lymphoma |volume=43 |issue= 6 |pages= 1189-201 |year= 2003 |pmid= 12152986 |doi=  }}
*{{cite journal  | author=Engel P, Eck MJ, Terhorst C |title=The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. |journal=Nat. Rev. Immunol. |volume=3 |issue= 10 |pages= 813-21 |year= 2003 |pmid= 14523387 |doi= 10.1038/nri1202 }}
*{{cite journal  | author=Stern MH, Soulier J, Rosenzwajg M, ''et al.'' |title=MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. |journal=Oncogene |volume=8 |issue= 9 |pages= 2475-83 |year= 1993 |pmid= 8361760 |doi=  }}
*{{cite journal  | author=Skare J, Wu BL, Madan S, ''et al.'' |title=Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. |journal=Genomics |volume=16 |issue= 1 |pages= 254-5 |year= 1993 |pmid= 8387453 |doi=  }}
*{{cite journal  | author=Coffey AJ, Brooksbank RA, Brandau O, ''et al.'' |title=Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. |journal=Nat. Genet. |volume=20 |issue= 2 |pages= 129-35 |year= 1998 |pmid= 9771704 |doi= 10.1038/2424 }}
*{{cite journal  | author=Sayos J, Wu C, Morra M, ''et al.'' |title=The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. |journal=Nature |volume=395 |issue= 6701 |pages= 462-9 |year= 1998 |pmid= 9774102 |doi= 10.1038/26683 }}
*{{cite journal  | author=Nichols KE, Harkin DP, Levitz S, ''et al.'' |title=Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 23 |pages= 13765-70 |year= 1998 |pmid= 9811875 |doi=  }}
*{{cite journal  | author=Poy F, Yaffe MB, Sayos J, ''et al.'' |title=Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. |journal=Mol. Cell |volume=4 |issue= 4 |pages= 555-61 |year= 1999 |pmid= 10549287 |doi=  }}
*{{cite journal  | author=Li SC, Gish G, Yang D, ''et al.'' |title=Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. |journal=Curr. Biol. |volume=9 |issue= 23 |pages= 1355-62 |year= 2000 |pmid= 10607564 |doi=  }}
*{{cite journal  | author=Sylla BS, Murphy K, Cahir-McFarland E, ''et al.'' |title=The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 13 |pages= 7470-5 |year= 2000 |pmid= 10852966 |doi= 10.1073/pnas.130193097 }}
*{{cite journal  | author=Benoit L, Wang X, Pabst HF, ''et al.'' |title=Defective NK cell activation in X-linked lymphoproliferative disease. |journal=J. Immunol. |volume=165 |issue= 7 |pages= 3549-53 |year= 2000 |pmid= 11034354 |doi=  }}
*{{cite journal  | author=Nagy N, Cerboni C, Mattsson K, ''et al.'' |title=SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. |journal=Int. J. Cancer |volume=88 |issue= 3 |pages= 439-47 |year= 2000 |pmid= 11054674 |doi=  }}
*{{cite journal  | author=Shlapatska LM, Mikhalap SV, Berdova AG, ''et al.'' |title=CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. |journal=J. Immunol. |volume=166 |issue= 9 |pages= 5480-7 |year= 2001 |pmid= 11313386 |doi=  }}
*{{cite journal  | author=Sayós J, Martín M, Chen A, ''et al.'' |title=Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. |journal=Blood |volume=97 |issue= 12 |pages= 3867-74 |year= 2001 |pmid= 11389028 |doi=  }}
*{{cite journal  | author=Morra M, Simarro-Grande M, Martin M, ''et al.'' |title=Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. |journal=J. Biol. Chem. |volume=276 |issue= 39 |pages= 36809-16 |year= 2001 |pmid= 11477068 |doi= 10.1074/jbc.M101305200 }}
*{{cite journal  | author=Latour S, Gish G, Helgason CD, ''et al.'' |title=Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. |journal=Nat. Immunol. |volume=2 |issue= 8 |pages= 681-90 |year= 2001 |pmid= 11477403 |doi= 10.1038/90615 }}
*{{cite journal  | author=Bottino C, Falco M, Parolini S, ''et al.'' |title=NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. |journal=J. Exp. Med. |volume=194 |issue= 3 |pages= 235-46 |year= 2001 |pmid= 11489943 |doi=  }}
*{{cite journal  | author=Liu A, Klein G, Bandobashi K, ''et al.'' |title=SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK. |journal=Immunol. Lett. |volume=80 |issue= 3 |pages= 181-8 |year= 2002 |pmid= 11803050 |doi=  }}
*{{cite journal  | author=Howie D, Simarro M, Sayos J, ''et al.'' |title=Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. |journal=Blood |volume=99 |issue= 3 |pages= 957-65 |year= 2002 |pmid= 11806999 |doi=  }}
*{{cite journal  | author=Aoukaty A, Tan R |title=Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. |journal=J. Biol. Chem. |volume=277 |issue= 15 |pages= 13331-7 |year= 2002 |pmid= 11815622 |doi= 10.1074/jbc.M112029200 }}
}}
{{refend}}


{{WH}}
== Further reading ==
{{WS}}
{{Refbegin|33em}}
* {{cite journal | vauthors = Sumegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, Yin L, Romco G, Klein E, Terhorst C, Lanyi A | title = A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses | journal = Leukemia & Lymphoma | volume = 43 | issue = 6 | pages = 1189–201 | date = Jun 2002 | pmid = 12152986 | doi = 10.1080/10428190290026240 }}
* {{cite journal | vauthors = Engel P, Eck MJ, Terhorst C | title = The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease | journal = Nature Reviews. Immunology | volume = 3 | issue = 10 | pages = 813–21 | date = Oct 2003 | pmid = 14523387 | doi = 10.1038/nri1202 }}
* {{cite journal | vauthors = Stern MH, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, Sigaux F, Kirsch IR | title = MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations | journal = Oncogene | volume = 8 | issue = 9 | pages = 2475–83 | date = Sep 1993 | pmid = 8361760 | doi =  }}
* {{cite journal | vauthors = Skare J, Wu BL, Madan S, Pulijaal V, Purtilo D, Haber D, Nelson D, Sylla B, Grierson H, Nitowsky H | title = Characterization of three overlapping deletions causing X-linked lymphoproliferative disease | journal = Genomics | volume = 16 | issue = 1 | pages = 254–5 | date = Apr 1993 | pmid = 8387453 | doi = 10.1006/geno.1993.1169 }}
* {{cite journal | vauthors = Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA | title = Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 95 | issue = 23 | pages = 13765–70 | date = Nov 1998 | pmid = 9811875 | pmc = 24894 | doi = 10.1073/pnas.95.23.13765 }}
* {{cite journal | vauthors = Poy F, Yaffe MB, Sayos J, Saxena K, Morra M, Sumegi J, Cantley LC, Terhorst C, Eck MJ | title = Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition | journal = Molecular Cell | volume = 4 | issue = 4 | pages = 555–61 | date = Oct 1999 | pmid = 10549287 | doi = 10.1016/S1097-2765(00)80206-3 }}
* {{cite journal | vauthors = Li SC, Gish G, Yang D, Coffey AJ, Forman-Kay JD, Ernberg I, Kay LE, Pawson T | title = Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A | journal = Current Biology | volume = 9 | issue = 23 | pages = 1355–62 | date = Dec 1999 | pmid = 10607564 | doi = 10.1016/S0960-9822(00)80080-9 }}
* {{cite journal | vauthors = Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E | title = The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 13 | pages = 7470–5 | date = Jun 2000 | pmid = 10852966 | pmc = 16569 | doi = 10.1073/pnas.130193097 }}
* {{cite journal | vauthors = Benoit L, Wang X, Pabst HF, Dutz J, Tan R | title = Defective NK cell activation in X-linked lymphoproliferative disease | journal = Journal of Immunology | volume = 165 | issue = 7 | pages = 3549–53 | date = Oct 2000 | pmid = 11034354 | doi = 10.4049/jimmunol.165.7.3549 }}
* {{cite journal | vauthors = Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi A, Székely L, Carbone E, Klein G, Klein E | title = SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines | journal = International Journal of Cancer | volume = 88 | issue = 3 | pages = 439–47 | date = Nov 2000 | pmid = 11054674 | doi = 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-# }}
* {{cite journal | vauthors = Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP | title = CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A | journal = Journal of Immunology | volume = 166 | issue = 9 | pages = 5480–7 | date = May 2001 | pmid = 11313386 | doi = 10.4049/jimmunol.166.9.5480 }}
* {{cite journal | vauthors = Sayós J, Martín M, Chen A, Simarro M, Howie D, Morra M, Engel P, Terhorst C | title = Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP | journal = Blood | volume = 97 | issue = 12 | pages = 3867–74 | date = Jun 2001 | pmid = 11389028 | doi = 10.1182/blood.V97.12.3867 }}
* {{cite journal | vauthors = Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C | title = Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients | journal = The Journal of Biological Chemistry | volume = 276 | issue = 39 | pages = 36809–16 | date = Sep 2001 | pmid = 11477068 | doi = 10.1074/jbc.M101305200 }}
* {{cite journal | vauthors = Latour S, Gish G, Helgason CD, Humphries RK, Pawson T, Veillette A | title = Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product | journal = Nature Immunology | volume = 2 | issue = 8 | pages = 681–90 | date = Aug 2001 | pmid = 11477403 | doi = 10.1038/90615 }}
* {{cite journal | vauthors = Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD, Moretta L, Moretta A | title = NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease | journal = The Journal of Experimental Medicine | volume = 194 | issue = 3 | pages = 235–46 | date = Aug 2001 | pmid = 11489943 | pmc = 2193462 | doi = 10.1084/jem.194.3.235 }}
* {{cite journal | vauthors = Liu A, Klein G, Bandobashi K, Klein E, Nagy N | title = SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK | journal = Immunology Letters | volume = 80 | issue = 3 | pages = 181–8 | date = Mar 2002 | pmid = 11803050 | doi = 10.1016/S0165-2478(01)00330-3 }}
* {{cite journal | vauthors = Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C | title = Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation | journal = Blood | volume = 99 | issue = 3 | pages = 957–65 | date = Feb 2002 | pmid = 11806999 | doi = 10.1182/blood.V99.3.957 }}
* {{cite journal | vauthors = Aoukaty A, Tan R | title = Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase | journal = The Journal of Biological Chemistry | volume = 277 | issue = 15 | pages = 13331–7 | date = Apr 2002 | pmid = 11815622 | doi = 10.1074/jbc.M112029200 }}
{{Refend}}
 
== [[Instagram|Ex]] ==
*
 
{{PDB Gallery|geneid=4068}}

Revision as of 22:06, 25 November 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

SH2 domain–containing protein 1A is a protein that in humans is encoded by the SH2D1A gene.[1][2][3] It is often called SLAM-associated protein (symbol SAP), where "SLAM" refers to signaling lymphocytic activation molecules. It is a SH2 domain–containing molecule (part of a family of such molecules) that plays a role in SLAM signaling. A putative function is as an adaptor for Fyn and competitor of phosphatases, leading to modulation of SLAM family function. SAP has been implicated in autoimmunity,[4] and a mutation of it is associated with X-linked lymphoproliferative disease.

Interactions

SH2D1A has been shown to interact with:

References

  1. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR (Oct 1998). "Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene". Nature Genetics. 20 (2): 129–35. doi:10.1038/2424. PMID 9771704.
  2. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C (Oct 1998). "The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM". Nature. 395 (6701): 462–9. doi:10.1038/26683. PMID 9774102.
  3. "Entrez Gene: SH2D1A SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome)".
  4. Menard M, et al. (2014). "Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance". Journal of Allergy and Clinical Immunology. 133 (4): 1149–1161. doi:10.1016/j.jaci.2013.10.051.
  5. Tangye SG, Nichols KE, Hare NJ, van de Weerdt BC (Sep 2003). "Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation". Journal of Immunology. 171 (5): 2485–95. doi:10.4049/jimmunol.171.5.2485. PMID 12928397.
  6. 6.0 6.1 Sayós J, Martín M, Chen A, Simarro M, Howie D, Morra M, Engel P, Terhorst C (Jun 2001). "Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP". Blood. 97 (12): 3867–74. doi:10.1182/blood.v97.12.3867. PMID 11389028.
  7. Tangye SG, van de Weerdt BC, Avery DT, Hodgkin PD (Jun 2002). "CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2". European Journal of Immunology. 32 (6): 1640–9. doi:10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S. PMID 12115647.
  8. 8.0 8.1 8.2 Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C (Sep 2001). "Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients". The Journal of Biological Chemistry. 276 (39): 36809–16. doi:10.1074/jbc.M101305200. PMID 11477068.
  9. Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E (Jun 2000). "The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B". Proceedings of the National Academy of Sciences of the United States of America. 97 (13): 7470–5. doi:10.1073/pnas.130193097. PMC 16569. PMID 10852966.
  10. Li C, Iosef C, Jia CY, Han VK, Li SS (Feb 2003). "Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors". The Journal of Biological Chemistry. 278 (6): 3852–9. doi:10.1074/jbc.M206649200. PMID 12458214.
  11. Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, Eck MJ (Feb 2003). "SAP couples Fyn to SLAM immune receptors". Nature Cell Biology. 5 (2): 155–60. doi:10.1038/ncb920. PMID 12545174.
  12. Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C (Feb 2002). "Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation". Blood. 99 (3): 957–65. doi:10.1182/blood.v99.3.957. PMID 11806999.

Further reading

Ex